Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hippocampal somatostatin-positive (SST+) GABAergic interneuron population is a specialized group of inhibitory neurons crucial for regulating hippocampal circuitry and memory formation (Source: Pelkey et al., 2017, Physiological Reviews). These neurons, which include subtypes like Oriens-lacunosum moleculare (O-LM) cells, primarily provide inhibition to the distal dendrites of pyramidal cells, thereby gating excitatory inputs and controlling synaptic plasticity (Source: Müller and Remy, 2018, Frontiers in Cellular Neuroscience). They play a fundamental role in generating network oscillations, particularly theta rhythms, which are essential for spatial navigation and memory encoding (Source: Klausberger and Somogyi, 2008, Science). In various neurological and psychiatric disorders, such as Alzheimer's disease and epilepsy, there is a notable loss or dysfunction of these SST+ interneurons, leading to network hyperexcitability and cognitive deficits (Source: Stefanelli et al., 2016, Neuron). While not a single molecular target, this cell population is a focus of therapeutic strategies aimed at restoring inhibitory balance through GABAergic modulation or somatostatin receptor agonism (Source: Liguz-Lecznar et al., 2016, Neuroscience & Biobehavioral Reviews).
Modulation of inhibitory neurotransmission via GABA release and somatostatin signaling to regulate pyramidal cell excitability and network synchrony.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hippocampal somatostatin-positive GABAergic interneuron population (Hippocampal SST+ interneurons).